The annual gathering brings together over 1,250 delegates from 65 countries to address pressing challenges in hospital management and healthcare delivery.
Researchers at The Rockefeller University have identified a rare genetic mutation that increases vulnerability to tuberculosis, potentially reshaping our understanding of tumour necrosis factor’s role in the immune system.
Researchers have developed a novel method to make skin and underlying tissues transparent using a common food dye, heralding potentially far-reaching applications for a wide range of medical diagnostics and certain treatments.
A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.
New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.
A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.
Researchers at Weill Cornell Medicine have utilised advanced machine learning techniques to identify three distinct subtypes of Parkinson’s disease, potentially paving the way for more personalised treatment approaches.
The National Institutes of Health (NIH) and VentureWell have awarded prizes totalling $160,000 to 11 winning teams and five honourable mentions in the 13th annual Design by Biomedical Undergraduate Teams (DEBUT) Challenge.
A groundbreaking method for monitoring antibiotic-resistant bacteria in hospitals could improve infection control and patient care.
Vitestro, a Dutch medical robotics firm, has announced that its autonomous blood drawing device has received CE marking, making it the first such device to be approved for commercial use in the European Union. This milestone, achieved in July 2024, signifies the device’s compliance with the European Medical Device Regulation (MDR) standards for safety and […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
